Companies

Protara Therapeutics, Inc. (TARA) SEC filings

CIK 0001359931 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)
Net income (USD)-66.0 M-47.3 M
Diluted EPS (USD/shares)-1.34-3.57-5.86

Latest filings

FiledFormDescriptionPeriod
2026-08-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-11S-8REGISTRATION STATEMENT
2026-08-1110-QQUARTERLY REPORT2026-06-30
2026-08-118-KCURRENT REPORT items 2.02,9.012026-08-11
2026-07-07SCHEDULE 13G/ASCHEDULE 13G/A
2026-07-014PRIMARY DOCUMENT2026-06-29
2026-06-298-KCURRENT REPORT items 5.022026-06-26
2026-06-29144144
2026-06-164PRIMARY DOCUMENT2026-06-15
2026-06-164PRIMARY DOCUMENT2026-06-15
2026-06-164PRIMARY DOCUMENT2026-06-15
2026-06-164PRIMARY DOCUMENT2026-06-15
2026-06-164PRIMARY DOCUMENT2026-06-15
2026-06-164PRIMARY DOCUMENT2026-06-15
2026-06-164PRIMARY DOCUMENT2026-06-15
2026-06-164PRIMARY DOCUMENT2026-06-15
2026-06-158-KCURRENT REPORT items 5.072026-06-12
2026-06-034PRIMARY DOCUMENT2026-06-02
2026-05-28424B5PROSPECTUS SUPPLEMENT
2026-05-22EFFECTEFFECT items ,,
2026-05-20CORRESPCORRESP
2026-05-19UPLOADUPLOAD
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-14S-3REGISTRATION STATEMENT
2026-05-1310-QQUARTERLY REPORT2026-03-31

Forms on file (last 1,000): 4 318, 8-K 128, 3 45, 10-Q 36, SC 13G 20, SC 13G/A 20, CORRESP 18, SCHEDULE 13G/A 16. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=TARA (0.002 USD), /gw/filings/filings?ticker=TARA&form=8-K, /gw/filings/facts?ticker=TARA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange